Tofacitinib for the treatment of severe rare skin diseases: a narrative review.
Fenglin LuoYuanyuan ZhangPing WangPublished in: European journal of clinical pharmacology (2024)
We explored the mechanism of action, efficacy, and safety considerations of tofacitinib and found that it can be used as a treatment option for rare skin diseases. However, multicenter clinical studies are needed to confirm the efficacy and safety of JAK inhibitors.